Ritholtz Wealth Management Makes New Investment in iShares Biotechnology ETF $IBB

Ritholtz Wealth Management acquired a new position in iShares Biotechnology ETF (NASDAQ:IBB) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 3,939 shares of the financial services provider’s stock, valued at approximately $665,000.

Other institutional investors and hedge funds have also bought and sold shares of the company. Darwin Wealth Management LLC purchased a new stake in iShares Biotechnology ETF in the 2nd quarter worth approximately $25,000. Ashton Thomas Securities LLC purchased a new stake in iShares Biotechnology ETF in the 3rd quarter worth approximately $36,000. Parkside Financial Bank & Trust lifted its holdings in iShares Biotechnology ETF by 48.6% in the 3rd quarter. Parkside Financial Bank & Trust now owns 266 shares of the financial services provider’s stock worth $38,000 after buying an additional 87 shares during the period. Close Asset Management Ltd lifted its holdings in iShares Biotechnology ETF by 25.5% in the 3rd quarter. Close Asset Management Ltd now owns 345 shares of the financial services provider’s stock worth $50,000 after buying an additional 70 shares during the period. Finally, Founders Financial Alliance LLC lifted its holdings in iShares Biotechnology ETF by 605.7% in the 3rd quarter. Founders Financial Alliance LLC now owns 374 shares of the financial services provider’s stock worth $54,000 after buying an additional 321 shares during the period. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Up 0.1%

NASDAQ IBB opened at $175.99 on Thursday. The stock has a 50 day simple moving average of $170.17 and a two-hundred day simple moving average of $166.81. iShares Biotechnology ETF has a fifty-two week low of $116.25 and a fifty-two week high of $179.64.

iShares Biotechnology ETF Cuts Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, March 20th. Stockholders of record on Tuesday, March 17th were paid a $0.1218 dividend. This represents a $0.49 dividend on an annualized basis and a dividend yield of 0.3%. The ex-dividend date was Tuesday, March 17th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.